Preliminary evidence of safety and effectiveness of Loxoprofen Sodium Cataplasm combined with physiotherapy for myofascial pain syndrome treatment: A randomized controlled pilot clinical trial
BackgroundMyofascial pain syndrome (MPS) is one of the most common causes of chronic skeletal muscle pain, which is closely related to skeletal muscle myofascial trigger point (MTRP). Since there is no first-line treatment for MPS, we investigated Loxoprofen Sodium Cataplasm combined with physiother...
Main Authors: | Xuewen Zhou, Xuelian Li, Ziyang Wang, Dong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.998327/full |
Similar Items
-
Preparation and in Vitro Evaluation of Soya Lecithin Based Nano Transfersomal Dispersion for Loxoprofen Sodium
by: Huda S. Kadhium, et al.
Published: (2019-12-01) -
Rheological and Mechanical Analyses of Felbinac Cataplasms by Using Box–Behnken Design
by: Jie Yang, et al.
Published: (2018-07-01) -
The effect of therapeutic physical modalities on pain, function, and quality of life in patients with myofascial pain syndrome: a systematic review
by: Peijue He, et al.
Published: (2023-05-01) -
Topical Delivery of Ketorolac Tromethamine via Cataplasm for Inflammatory Pain Therapy
by: Zhiyuan Hou, et al.
Published: (2023-05-01) -
Simultaneous stereoisomeric separation of loxoprofen sodium and its alcohol metabolites. Application to a stereoselective pharmacokinetic study
by: Shirong Cao, et al.
Published: (2023-08-01)